|
|
Article: Publication No. WO/2009/021121 Published on Oct. 29, Assigned to WYETH, Viropharma for Hcv Replicon Variant Characterization, Identification (American Inventors)
- Article from:
- US Fed News Service, Including US State News
- Article date:
- October 31, 2009
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
GENEVA, Oct. 31 -- Michael James Flint, Anita Y.M. Howe and Anne McClure Deatly, all from the U.S., have developed an identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase.
The patent has been assigned to WYETH, Madison, N.J. and Viropharma Inc., Exton, Pa.
According to an abstract posted by the World Intellectual Property Organization: "The present invention provides methods of decreasing the frequency of emergence, decreasing the level of resistance, and delaying the emergence of a treatment-resistant hepatitis C viral infection, by administering to a subject, either in combination or in series, an inhibitor of the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Patent No. 07601500 Issued on Oct. 13, Assigned to Intervet ...
US Fed News Service, Including US State News;
October 15, 2009 ;
491 words
... ... protection of equines against viral infection .The inventor was issued ... adequate protection against viral infection in equines can be achieved ... information about US Fed News contract awards please ... Sarabjit Jagirdar, US Fed News, Email:- htsyndication ...
|
|